Webinar Presentation and Transcript added to Final Guidance on Use of International Standard ISO 10993-1, Biological evaluation of medical devices

On July 21, 2016, the FDA will hold a webinar for industry to review the Use of International Standard ISO 10993-1, “Biological evaluation of medical devices – Part 1: Evaluation and testing within a risk management process” final guidance document. The recommendations in this final guidance clarify and update how medical device developers may use…

Fluoroquinolone Antibacterial Drugs for Systemic Use: Drug Safety Communication

Including the following currently available fluoroquinolones Avelox (moxifloxacin) Cipro (ciprofloxacin) Cipro extended-release (ciprofloxacin extended-release)Factive (gemifloxacin) Levaquin (levofloxacin) Ofloxacin (generic brand) [Posted 07/26/2016] AUDIENCE: Family Practice, Infectious Disease, Neurology, Pharmacy, Patient ISSUE: FDA approved changes to the labels of fluoroquinolone antibacterial drugs for systemic use (i.e., taken by mouth or by injection). These medicines are associated…

24 Hour Summary (Dexcom) posted for July 21, 2016 Clinical Chemistry and Clinical Toxicology Devices Panel of the Medical Devices Advisory Committee

%PDF-1.7 % 99 0 obj stream xyMǿIȾ31CTRRcP RcjȒ0HC֏y|̹۹u~˼x=y{9YYYs!B!D$(!B!!W{^B!BB!B!yzE!B!ZzE!B!ZzE!B!Z_B!BHQ^BC”B!B”B!@”B!@”B!@”B!@”B!@”B!@”B!@”B!@”B!@”B!@”B!@”B!@”B!@”B!@”B!@”B!@”B!@”B!@”B!@”B!@”B!@”B!@”B!@”B!@”B!@”B!@”B!@”B!@”B!@”B!@”B!@”B!@”B!@”B!@”B!@”B!@”B!@”B!@”B!@”B!@”B!@”B!@”B!@”B!@”B!@”B!@”RokX-F϶BQ|K”Rȑ/aTK*!hdK”RɃJh2 |U@QBɖzE!ТeP,”)-BH!’*E(YTEQZ)B:-BH!M?~|۷o߼yZīWRSS;/^FO8pP˗/8DPˇ4jTFFQ^ fUZ޿Jql80)?*5BHхzE!h;vu8ϓ’O^u”SNXq ݃A=|:{, CǎCIII?=:*ٳ7n;wG?~QGFF*Bqqqoƞ,ݭUzTzE!hˀ===]EyD,X